PBL case study featured in July edition of Manufacturing Chemist

Purification expertise

In this case study, Dr David Gervais, Head of Product and Fermentation Development at Porton Biopharma  describes how a non-GMP enzyme manufacturing process has been successfully converted from a native to a recombinant one using bioinformatics and next-generation sequencing (NGS).

Demonstrating PBL’s capability to deliver significant improvements in yield, purity and activity for customer’s products.

read more

Automating the production of life-saving drugs

PBL is featured in a technical article in Manufacturing Chemist on “Automating the production of life-saving drugs” in regards to the new Bosch integrated filling line that we have installed to meet the growing demand for our Erwinase product, which is used to treat childhood leukaemia.

read more

Porton Biopharma Appoints New Chair

Porton Biopharma Ltd is very pleased to announce the appointment of a new non-executive Chair for the Company, Barry Clare.  Barry is a pioneering healthcare business leader with extensive experience in the healthcare industry and an experienced non-executive director and company chair.

read more